The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy*; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003863:Depression / Q000145:classification / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000097:blood; D010624:Phenelzine / Q000627:therapeutic use*; D010919:Placebos; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales
D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D000639:Amitriptyline; D002707:Chlordiazepoxide; D010624:Phenelzine